Cargando…
Cerebrospinal fluid markers for synaptic function and Alzheimer type changes in late life depression
To explore markers for synaptic function and Alzheimer disease (AD) pathology in late life depression (LLD), predementia AD and normal controls (NC). A cross-sectional study to compare cerebrospinal fluid (CSF) levels of neurogranin (Ng), Beta-site amyloid-precursor-protein cleaving enzyme1 (BACE1),...
Autores principales: | Siafarikas, Nikias, Kirsebom, Bjørn-Eivind, Srivastava, Deepak P., Eriksson, Cecilia M., Auning, Eirik, Hessen, Erik, Selbaek, Geir, Blennow, Kaj, Aarsland, Dag, Fladby, Tormod |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514484/ https://www.ncbi.nlm.nih.gov/pubmed/34645914 http://dx.doi.org/10.1038/s41598-021-99794-9 |
Ejemplares similares
-
Author Correction: Cerebrospinal fluid markers for synaptic function and Alzheimer type changes in late life depression
por: Siafarikas, Nikias, et al.
Publicado: (2022) -
Correlates of Subjective and Mild Cognitive Impairment: Depressive Symptoms and CSF Biomarkers
por: Grambaite, Ramune, et al.
Publicado: (2013) -
In Brief Neuropsychological Assessment, Amnestic Mild Cognitive Impairment (MCI) Is associated with Cerebrospinal Fluid Biomarkers for Cognitive Decline in Contrast to the Prevailing NIA-AA MCI Criterion
por: Hessen, Erik, et al.
Publicado: (2019) -
Impaired synaptic function is linked to cognition in Parkinson's disease
por: Selnes, Per, et al.
Publicado: (2017) -
Hippocampal subfield atrophy in relation to cerebrospinal fluid biomarkers and cognition in early Parkinson’s disease: a cross-sectional study
por: Stav, Ane Løvli, et al.
Publicado: (2016)